Live Breaking News & Updates on Guidance Documents Not Impacted

The COVID-19 pandemic presented the U.S. Food and Drug Administration (FDA or Agency) with a monumental task of shifting its operations and the way it approached the regulation of. ....

Health Care Professionals , Public Health Emergency On Formal Meetings , Drug Administration , Development Of Abbreviated New Drug Applications During , Public Health Emergency , Public Health Emergency Revised , Health Emergency , Federal Register , Guidance Documents That Will Expire With , Transition Plan , Investigational Cellular , Gene Therapy Products During , Abbreviated New Drug Applications During , Formal Meetings , User Fee Applications Questions , Certain Drugs , Hospitalized Patients , Outsourcing Facilities During , General Considerations , Biological Products , Quite Finished , Guidance Documents That Will Remain , Supply Chain , Biological Product Inspections During , Health Emergency Questions , Face Shields ,